Skip to main content
Top

Drugs

Issue 11/2009

Content (8 Articles)

The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

  • Review Article

Niki Katsiki, Eleni Georgiadou, Apostolos I. Hatzitolios

Streptokinase and Enoxaparin as an Alternative to Fibrin-Specific Lytic-Based Regimens

  • Original Research Article

Roberto R. Giraldez, Stephen D. Wiviott, Jose C. Nicolau, Satishkumar Mohanavelu, David A. Morrow, Elliott M. Antman, Robert P. Giugliano

Statin Use and Risk of Colorectal Cancer in a Cohort of Middle-Aged Men in the US

  • Original Research Article

E. Dawn Flick, Laurel A. Habel, K. Arnold Chan, Reina Haque, Virginia P. Quinn, Stephen K. Van Den Eeden, Barbara Sternfeld, Endel J. Orav, John D. Seeger, Charles P. Quesenberry Jr, Bette J. Caan

Budesonide/Formoterol Pressurized Metered-Dose Inhaler

  • Adis Drug Profile

Katherine A. Lyseng-Williamson

Ixabepilone

  • Adis Drug Profile

Marit D. Moen

Rabbit Antithymocyte Globulin (Thymoglobulin®)

  • Adis Drug Evaluation

Emma D. Deeks, Gillian M. Keating

Etoricoxib

  • Adis Drug Evaluation

Katherine F. Croom, M. Asif A. Siddiqui

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images